Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples

Anyplex II HPV‐28 (HPV‐28) can detect individually 28 HPV genotypes. We assessed the agreement between linear array HPV genotyping (LA‐HPV) and HPV‐28 for detection of 27 HPV genotypes in 410 stored anogenital samples (75 anal samples, 335 physician‐collected cervical samples) collected over 5 years from 410 individuals (13 men, 397 women), including 202 HIV‐seropositive individuals. HPV DNA was detected in 393 (95.9%, 95% confidence interval [CI]: 93.4–97.4) and 382 (93.2%, 95% CI: 90.3–95.3) samples with HPV‐28 and LA‐HPV (p = 0.13), respectively, for a good agreement of 96.3% (κ = 0.65). Of the 10503 HPV typing results, 10195 (780 positive, 9577 negative) were concordant, for an agreement of 97.1% (95% CI: 96.7–97.4) and an excellent of κ = 0.82 (95% CI: 0.80–0.84). The mean type‐specific concordance for 27 genotypes was 97.0%, 95% CI: 95.8–98.5 (κ = 0.86 ± 0.07, 95% CI: 0.83–0.88). Excellent agreement was obtained individually for all high‐risk genotypes (κ = 0.81–0.97) and for most other genotypes except for types 42, 44, 54, 68, and 69. The mean number of types per sample in discordant samples detected with LA‐HPV (3.0, 95% CI: 2.7–3.4) was greater than in concordant samples (1.4, 95% CI: 1.3–1.5; p< 0.001). In conclusion, HPV‐28 compared favorably with LA‐HPV, but was more frequently positive for HPV42 and HPV68.

[1]  J. Dillner,et al.  The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing. , 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  C. Söderhäll,et al.  Maternal Human Papillomavirus Infections at Mid-Pregnancy and Delivery in a Scandinavian Mother-Child Cohort Study. , 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[3]  J. Mossong,et al.  Characterization and Diversity of 243 Complete Human Papillomavirus Genomes in Cervical Swabs Using Next Generation Sequencing , 2020, Viruses.

[4]  H. Sousa,et al.  The prevalence and risk-factors of oral HPV DNA detection among HIV-infected men between men who have sex with men and heterosexual men , 2020, Infectious diseases.

[5]  J. Mossong,et al.  Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg. , 2019, Cancer epidemiology.

[6]  H. Sousa,et al.  High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program , 2019, Papillomavirus research.

[7]  Zita Aleyo Nodjikouambaye,et al.  High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N’Djamena, Chad , 2019, PloS one.

[8]  A. Burchell,et al.  Human Papillomavirus Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study: Protocol Describing Design, Methods, and Research Goals , 2019, JMIR research protocols.

[9]  M. Poljak,et al.  Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework , 2018, Journal of Clinical Microbiology.

[10]  C. Achtari,et al.  Impact of HPV vaccination with Gardasil® in Switzerland , 2017, BMC Infectious Diseases.

[11]  S. Garland,et al.  HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples , 2017, Papillomavirus research.

[12]  D. Geraets,et al.  Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection. , 2017, Journal of virological methods.

[13]  A. Burchell,et al.  The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV , 2017, The Journal of infectious diseases.

[14]  A. Burchell,et al.  Y Chromosome DNA in Women's Vaginal Samples as a Biomarker of Recent Vaginal Sex and Condom Use With Male Partners in the HPV Infection and Transmission Among Couples Through Heterosexual Activity Cohort Study , 2017, Sexually transmitted diseases.

[15]  S. Garland,et al.  Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities , 2017, European Journal of Clinical Microbiology & Infectious Diseases.

[16]  S. Trottier,et al.  HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine. , 2016, Vaccine.

[17]  J. Mossong,et al.  Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples. , 2016, Diagnostic microbiology and infectious disease.

[18]  M. Poljak,et al.  Commercially available molecular tests for human papillomaviruses (HPV): 2015 update. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[19]  R Sahli,et al.  Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[20]  E. Burd Human Papillomavirus Laboratory Testing: the Changing Paradigm , 2016, Clinical Microbiology Reviews.

[21]  R. Sahli,et al.  Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV Assay for Human Papillomavirus Genotyping , 2013, Journal of Clinical Microbiology.

[22]  J. Dillner,et al.  Global Improvement in Genotyping of Human Papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study , 2013, Journal of Clinical Microbiology.

[23]  J. Dillner,et al.  The 2010 Global Proficiency Study of Human Papillomavirus Genotyping in Vaccinology , 2012, Journal of Clinical Microbiology.

[24]  J. Dillner,et al.  Global Proficiency Study of Human Papillomavirus Genotyping , 2010, Journal of Clinical Microbiology.

[25]  A. Burchell,et al.  Human Papillomavirus Infections Among Couples in New Sexual Relationships , 2010, Epidemiology.

[26]  E. Franco,et al.  Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. , 2009, The Journal of infectious diseases.

[27]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[28]  Diane Solomon,et al.  Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study , 2007, Journal of Clinical Microbiology.

[29]  Stephen D Walter,et al.  Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. , 2007, The New England journal of medicine.

[30]  E. Franco,et al.  Confirmatory Real-Time PCR Assay for Human Papillomavirus (HPV) Type 52 Infection in Anogenital Specimens Screened for HPV Infection with the Linear Array HPV Genotyping Test , 2007, Journal of Clinical Microbiology.

[31]  P. Schlag,et al.  Enhanced Detection and Typing of Human Papillomavirus (HPV) DNA in Anogenital Samples with PGMY Primers and the Linear Array HPV Genotyping Test , 2006, Journal of Clinical Microbiology.

[32]  S. Vernon,et al.  Comparison of Human Papillomavirus Detection and Typing by Cycle Sequencing, Line Blotting, and Hybrid Capture , 2000, Journal of Clinical Microbiology.

[33]  E. Franco,et al.  Nonisotopic Detection and Typing of Human Papillomavirus DNA in Genital Samples by the Line Blot Assay , 1999, Journal of Clinical Microbiology.

[34]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[35]  M. Poljak,et al.  Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework. , 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[36]  M. Salma,et al.  Clinical validation of Anyplex TM II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening , 2016 .